11Lun·

As I already have Vertex $VRTX (-3,11 %) already in my portfolio, I will simply buy the competitor after the good quarterly figures. Perhaps there will be a takeover.

https://www.marketbeat.com/instant-alerts/nasdaq-krys-boost-price-target-2024-11-05/

08.11

Krystal Biotech

Compró 10 a 181,10 €

1811,00 €

28 Comentarios

Soprano@Soprano

11Lun

I would only buy BioTech from established companies. There are simply too many stalls to say what will and won't work.

•

Usuario eliminado

10Lun

Comentario eliminado

Tenbagger2024@Tenbagger2024

10Lun

@Soprano
At $EVT and $HALO you can see that there is a lot of imagination in the small ones and that takeovers can happen quickly.

••

Tenbagger2024@Tenbagger2024

10Lun

@Memo0606
Otherwise, take $VRTX with a market capitalization of 120 billion.
Or $UCB with a market capitalization of 34 billion.
Or $UTHR with a market capitalization of 16 billion.

••

Usuario eliminado

10Lun

Comentario eliminado

Tenbagger2024@Tenbagger2024

10Lun

@Memo0606
What's your next purchase?

••

Usuario eliminado

10Lun

Comentario eliminado

Tenbagger2024@Tenbagger2024

10Lun

@Memo0606
Maybe I'll buy from $IESC and $NU

••

Tenbagger2024@Tenbagger2024

10Lun

@Memo0606
Why don't you buy more from Hims?

••

Usuario eliminado

10Lun

Comentario eliminado

Tenbagger2024@Tenbagger2024

10Lun

@Memo0606
What bothers me about Novo is the report about the severe side effects and muscle loss and that the US government plans to regulate prices

••

Ver todas las 6 respuestas adicionales

MrStonkss@MrStonkss

11Lun

How do they differ?

••

Tenbagger2024@Tenbagger2024

11Lun

@MrStonkss
Among others in size, turnover. market capitalization, etc. Vertex has a larger portfolio

••

MrStonkss@MrStonkss

11Lun

@Tenbagger2024 Do you have any insider information regarding a takeover or do you just think so? Would the share have potential even without the takeover and would a takeover be possible with regard to the antitrust authorities?

••

Tenbagger2024@Tenbagger2024

11Lun

@MrStonkss
https://www.deraktionaer.de/artikel/pharma-biotech/aktionaer-hot-stock-krystal-biotech-nicht-zu-bremsen-naechstes-rekordhoch-20361473.html

•